3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
10
Carcinoma, Non-Small-Cell Lung
6
Prostatic Neoplasms
4
Lymphoma, Large B-Cell, Diffuse
4
Leukemia, Myeloid, Acute
4
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Recurrence
3
Ovarian Neoplasms
3
Neoplasm Metastasis
3
Multiple Myeloma
3
Lung Neoplasms
3
Thrombosis
2
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Neoplasms
2
Nasopharyngeal Carcinoma
2
Esophageal Squamous Cell Carcinoma
2
Disease
2
Carcinoma, Transitional Cell
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Cancer, Papillary
1
Thrombophilia
1
Thrombocytopenia
1
Thoracic Neoplasms
1
Skin Neoplasms
1
Pituitary Neoplasms
1
Pediatric Solid Tumor, Unspecified, Protocol Specific
1
Interventions
Cisplatin
4
Etoposide
3
Carboplatin
3
etoposide phosphate
2
Paclitaxel
2
Bleomycin
2
pralsetinib
1
pembrolizumab
1
pegfilgrastim
1
Standard of Care
1
Specimen Handling
1
Respiratory Physiological Phenomena
1
Practice Guidelines as Topic
1
Platinum
1
Pemetrexed
1
Magnetic Resonance Spectroscopy
1
Injections
1
Ifosfamide
1
Granulocyte Colony-Stimulating Factor
1
Gemcitabine
1
Filgrastim
1
Biopsy
1
Aprepitant
1
130-nm albumin-bound paclitaxel
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Neoplasms, Germ Cell and Embryonal
×
Injections
×
Clear all
NCT02582697
2025-06-15
P3BEP
University of Sydney
Phase 3
Recruiting
500 enrolled